Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for XOFIGO

    Client Email Product

    XOFIGO

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    0

    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    0

    API REF. PRICE (USD / KG)

    0

    API Market Place

    0

    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    1
    Europe

    Europe

    1
    Canada

    Canada

    1
    Australia

    Australia

    0

    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    351.00

    FDF Market Place

    0

    EXCIPIENTS
    3
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    17
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Bayer, Novartis stack up radiopharmaceutical data at #ESMO21; starts debate
    Bayer, Novartis stack up radiopharmaceutical data at #ESMO21; starts debate

    https://endpts.com/as-bayer-novartis-stack-up-their-radiopharmaceutical-data-at-esmo21-a-key-debate-takes-shape/

    Amber Tong ENDPTS
    20 Sep 2021
    Share Share
    Bayer AG's Xofigo (radium Ra223 dichloride) Receives Approval in Europe
    Bayer AG's Xofigo (radium Ra223 dichloride) Receives Approval in Europe

    https://www.ema.europa.eu/documents/product-information/xofigo-epar-product-information_en.pdf

    EMA
    12 Oct 2018
    Share Share
    EMA restricts use of prostate cancer medicine Xofigo
    EMA restricts use of prostate cancer medicine Xofigo

    EMA
    27 Jul 2018
    Share Share
    Adempas maker Bayer launches new hypertension support group
    Adempas maker Bayer launches new hypertension support group

    https://www.fiercepharma.com/marketing/adempas-maker-bayer-connects-hypertension-patients-new-mentoring-group

    Carly Helfand FIERCE PHARMA
    14 Jul 2018
    Share Share
    Bayer's growth-driving quintet? Better, thanks to Stivarga & Xofigo stall
    Bayer's growth-driving quintet? Better, thanks to Stivarga & Xofigo stall

    https://www.fiercepharma.com/pharma/currency-headwind-bayer-s-pharma-meets-expectation-as-consumer-slides-again

    Angus Liu FIERCE PHARMA
    03 May 2018
    Share Share
    What’s killing patients in Bayer’s Xofigo combo study? Researchers halt study
    What’s killing patients in Bayer’s Xofigo combo study? Researchers halt study

    https://endpts.com/bayer-hit-with-a-setback-as-xofigo-zytiga-combo-phiii-study-is-halted-early-to-examine-causes-of-a-higher-death-rate/

    John Carroll ENDPTS
    02 Dec 2017
    Share Share
    Another record year for Bayer – good progress with the acquisition of Monsanto
    Another record year for Bayer – good progress with the acquisition of Monsanto

    http://www.press.bayer.com/baynews/baynews.nsf/id/A6E220D8E59FD1C2C12580CF001BD137

    PRESS RELEASE
    23 Feb 2017
    Share Share
    Bayer plots Stivarga expansion with new top-line data in hand
    Bayer plots Stivarga expansion with new top-line data in hand

    http://www.fiercepharma.com/pharma/bayer-plots-stivarga-expansion-new-top-line-data-hand

    Carly Helfand FIERCE PHARMA
    05 May 2016
    Share Share
    AZ approval for Tagrisso in Japan a big change to NSCLC treatment option in Asia
    AZ approval for Tagrisso in Japan a big change to NSCLC treatment option in Asia

    http://www.fiercepharmaasia.com/story/az-approval-tagrisso-japan-big-change-nsclc-treatment-options-asia/2016-03-29

    EJ Lane FIERCE PHARMA ASIA
    30 Mar 2016
    Share Share
    NHS cancer patients gain access to four new therapies
    NHS cancer patients gain access to four new therapies

    http://www.pharmatimes.com/Article/16-01-27/NHS_cancer_patients_gain_access_to_four_new_therapies.aspx

    Selina McKee PHARMATIMES
    27 Jan 2016
    Share Share
    Bayer Presents Latest Xofigo Injection Research at ASCO GU 2016
    Bayer Presents Latest Xofigo Injection Research at ASCO GU 2016

    http://www.prnewswire.com/news-releases/bayer-presents-latest-xofigo-radium-ra-223-dichloride-injection-research-at-asco-gu-2016-300198976.html

    PR NEWS WIRE
    04 Jan 2016
    Share Share
    NICE OK's restricted use of Bayer's prostate cancer drug
    NICE OK's restricted use of Bayer's prostate cancer drug

    http://www.pharmatimes.com/Article/15-11-19/NICE_OK_s_restricted_use_of_Bayer_s_prostate_cancer_drug.aspx

    Selina McKee PHARMATIMES
    19 Nov 2015
    Share Share
    NICE backs Bayer's Xofigo but rejects Ferring's Firmagon
    NICE backs Bayer's Xofigo but rejects Ferring's Firmagon

    http://www.pharmatimes.com/Article/15-06-05/NICE_backs_Bayer_s_Xofigo_but_rejects_Ferring_s_Firmagon.aspx

    Selina Mckee PHARMA TIMES
    08 Jun 2015
    Share Share
    Australia's Sirtex eyed by Bayer for radioactive attraction?
    Australia's Sirtex eyed by Bayer for radioactive attraction?

    http://www.fiercepharmaasia.com/story/australias-sirtex-eyed-bayer-radioactive-attraction/2015-05-18

    Ej Lane FIERCE PHARMA ASIA
    18 May 2015
    Share Share
    Strong start to the year for Bayer
    Strong start to the year for Bayer

    http://www.worldpharmanews.com/bayer/3078-strong-start-to-the-year-for-bayer?utm_content=buffer404ef&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

    WORLD PHARMA NEWS
    01 May 2015
    Share Share
    Drug shortages become issue in Teva and Mylan hook-up
    Drug shortages become issue in Teva and Mylan hook-up

    http://www.fiercepharmamanufacturing.com/story/drug-shortages-becomes-issue-teva-and-mylan-hook/2015-04-30

    Eric Palmer FIERCE PHARMA MANUFACTURING
    30 Apr 2015
    Share Share
    Bayer's Eylea Cleared for Wider Use in Europe
    Bayer's Eylea Cleared for Wider Use in Europe

    http://www.pmlive.com/pharma_news/bayers_eylea_cleared_for_wider_use_in_europe_664304

    Phil Taylor PMLIVE
    27 Feb 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search